Here, we further found that PD-L1/PD-1 signaling inhibited TRPV1 activity via SHP-1 in primary sensory neurons and thereby suppressed and delayed the development of bone cancer pain in mice. This evidence concerns the gene TRPV1 and bone neoplasm.